Low Psychosine in Krabbe Disease with Onset in Late Infancy: A Case Report
Krabbe disease (KD) is a rare inherited neurodegenerative disorder caused by a deficiency in galactocerebrosidase enzyme activity, which can present in early infancy, requiring an urgent referral for hematopoietic stem cell transplantation, or later in life. Newborn screening (NBS) for KD requires i...
Main Authors: | Camille S. Corre, Dietrich Matern, Joan E. Pellegrino, Carlos A. Saavedra-Matiz, Joseph J. Orsini, Robert Thompson-Stone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/7/2/28 |
Similar Items
-
Newborn Screening for Krabbe Disease—Illinois Experience: Role of Psychosine in Diagnosis of the Disease
by: Khaja Basheeruddin, et al.
Published: (2021-05-01) -
Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
by: Dietrich Matern, et al.
Published: (2024-01-01) -
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease
by: Zackary Herbst, et al.
Published: (2020-03-01) -
Exploration of protective strategies against oligodendrocyte cell death in Krabbe disease models
by: Gonzalo Arboleda
Published: (2015-02-01) -
Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease
by: Aimee R. Herdt, et al.
Published: (2023-07-01)